QR kód

Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells

Abstract Background The efficacy and safety of multikinase inhibitor anlotinib have been confirmed in the treatment of advanced non-small cell lung cancer (NSCLC). However, the direct functional mechanisms of tumor lethality mediated by anlotinib were not fully elucidated, and the underlying mechani...

Celý popis

Uloženo v:
Hlavní autoři: Lijun Liang, Kaiyuan Hui, Chenxi Hu, Yixuan Wen, Shikun Yang, Panrong Zhu, Lei Wang, Youyou Xia, Yun Qiao, Wen Sun, Jiayan Fei, Ting Chen, Fenghua Zhao, Baocheng Yang, Xiaodong Jiang
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2019-02-01
Edice:Journal of Experimental & Clinical Cancer Research
Témata:
Anlotinib
Autophagy
NSCLC
Apoptosis
Anti-angiogenesis
VEGFA
On-line přístup:http://link.springer.com/article/10.1186/s13046-019-1093-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky